Shinepharm Hot-Selling 10iu/Ml Oxytocin Injection Manufactured for Human Use Western Medicine

• Customization: Available
• Application: Internal Medicine
• Usage Mode: Intravenous/ Intramuscular
• Model NO.: AMC14018-01
• Suitable for: Elderly, Children, Adult
• State: Liquid
• Shape: Pre Filled Syringe
• Type: Biological Products
• Pharmaceutical Technology: Chemical Synthesis
• Drug Reg./Approval No.: Pairs
• Registration Dossiers: Available
• Shelf Life: 3years
• OEM/ODM: Support
• Standard Available: Bp, USP or Cp
• Delivery Time: 30~60 Days
• Certification: GMP
• Transport Package: 10′ S/Box
• Specification: 10IU/ml
• Trademark: Shinepharm/OEM
• Origin: China
• HS Code: 300490909
• Production Capacity: 200000 Boxes

Product Description

 

Shinepharm Hot-selling 10iu/Ml Oxytocin Injection Manufactured for Human Use Western Medicine

 

Product Description

Indications
Oxytocin is indicated by the parenteral route for nonelective of labor for medical reasons and for stimulation or reinforcement of laborin patients with dysfunctional interia parenteral oxytocin is also indicated for management of inevitable, incomplete or missed abortion, as well as to produce uterine contractions during the third stage of labour and to control postpartum bleeding or hemorrhage oxytocin lias been administered parenterally to assess fetal respiratory capabilities in high-risk pregnancies
Oxytocin has been intranasally for stimulation of milk jcction when it is impaired
Usual adult dose:
Oxytocin challenge test Intravenous infusion, initially 0.5 milliunil per minute, doubled every twenty minules as necessary to the effcctivc dose (usally 5 to 6 milliunits per minuli;) Wlwn three moderate uterine cuntroction (iluration of forty to sixty scconds) <x;cur in unu icn minute interval Ihc infusion is discontinued and baseline nnd ojtylocin-induccd fclal heart rtUcft urc compared .If there is no change in fclul heart rale, repeat the test aflcr one week, in the    of a suspcd    re|>cal within twenty-four tlUURf
 
Induction or stimulation of labour:
 
Intravenous infusion,initially no more than 1 to 2 milliunits(0.01 to 0.02 units)per
 
minute,increased every fifiteen to thirty minutes in increments of 1 to 2 milliunits per
 
minute until a contraction pattern similar to that of normal labour is obtained up to a
 
maximum of 20 milliunits per minute (usually 2to 5 milliunits per minute).The rate may
 
bereduced once labour is established.
 
Control of postpartum uterine bleeding:
Intravenous infusion,10 units at a rate of 20 lo 40 milliunits per minute  following delivery of the infant(s) and preterably the placenta(s).A rate of 20 to 100 milliunits per minute may be used following abortion.
Inlramuscular,3 to 10 unils after delivery of the placenta(s).
 
Specification:(1)0,5ml:2,5unit (2)1 ml:5Unit (3) 1 ml:10Unit
 
Packing and storage:
Store beJow 20 Centigrade, Preferably between centigrade to 4 centigrade,
dry place, away from light, protect from freezing.
 
Validity: Three Years
 

Workshop

 

--------------------------------------------------------------------------------------------------